Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution

Metabolism: Clinical and Experimental

Volumn 56, Issue 7, 2007, Pages 939-946

  Haugaard, Steen B ^a   Andersen, Ove ^a   Halsall, Ian ^b   Iversen, Johan ^a   Hales, Charles Nicholas ^b   Madsbad, Stein ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY FAT DISTRIBUTION; CELL FUNCTION; CLINICAL ARTICLE; DIABETES MELLITUS; GLUCOSE METABOLISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPODYSTROPHY; MALE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AREA UNDER CURVE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; PROINSULIN;

EID: 34250019915     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.02.007     Document Type: Article

References (51)

1. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-F58
2. Hadigan C., Meigs J.B., Corcoran C., et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 32 (2001) 130-139
3. Haugaard S.B., Andersen O., Madsbad S., et al. Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy. Diabetes 54 (2005) 3474-3483
4. Carr A., Samaras K., Thorisdottir A., et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353 (1999) 2093-2099
5. Haugaard S.B., Andersen O., Volund A., et al. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy. Clin Endocrinol (Oxf) 62 (2005) 354-361
6. Bonnet F., Balestre E., Bernardin E., et al. Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999-2003. Antivir Chem Chemother 16 (2005) 63-67
7. Carr A., Miller J., Law M., et al. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14 (2000) F25-F32
8. Hadigan C., Rabe J., Meininger G., et al. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution. Am J Clin Nutr 77 (2003) 490-494
9. Haugaard S.B., Andersen O., Pedersen S.B., et al. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism 55 (2006) 175-182
10. Johnson J.A., Albu J.B., Engelson E.S., et al. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab 286 (2004) E261-E271
11. Chen D., Misra A., and Garg A. Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 87 (2002) 4845-4856
12. Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
13. Friis-Moller N., Weber R., Reiss P., et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 17 (2003) 1179-1193
14. Friis-Moller N., Sabin C.A., Weber R., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
15. Haugaard S.B., Andersen O., Storgaard H., et al. Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells. Am J Physiol Endocrinol Metab 287 (2004) E677-E685
16. Haugaard S.B., Andersen O., Pedersen S.B., et al. Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy. HIV Med 7 (2006) 163-172
17. Woerle H.J., Mariuz P.R., Meyer C., et al. Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52 (2003) 918-925
18. Iozzo P., Pratipanawatr T., Pijl H., et al. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. Am J Physiol Endocrinol Metab 280 (2001) E712-E719
19. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46 (2003) 3-19
20. Storlien L., Oakes N.D., and Kelley D.E. Metabolic flexibility. Proc Nutr Soc 63 (2004) 363-368
21. Krogh-Madsen R., Plomgaard P., Keller P., et al. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab 286 (2004) E234-E238
22. Halban P.A. Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia 37 Suppl 2 (1994) S65-S72
23. Hales C.N. The pathogenesis of NIDDM. Diabetologia 37 Suppl 2 (1994) S162-S168
24. Wareham N.J., Byrne C.D., Williams R., et al. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22 (1999) 262-270
25. Zethelius B., Byberg L., Hales C.N., et al. Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men-report from 27 years of follow-up study. Diabetologia 46 (2003) 20-26
26. Bavenholm P., Proudler A., Tornvall P., et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92 (1995) 1422-1429
27. Zethelius B., Byberg L., Hales C.N., et al. Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105 (2002) 2153-2158
28. Sobey W.J., Beer S.F., Carrington C.A., et al. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 260 (1989) 535-541
29. Hovorka R., Soons P.A., and Young M.A. ISEC: a program to calculate insulin secretion. Comput Methods Programs Biomed 50 (1996) 253-264
30. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
31. Behrens G., Dejam A., Schmidt H., et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 13 (1999) F63-F70
32. Hruz P.W., Murata H., Qiu H., et al. Indinavir induces acute and reversible peripheral insulin resistance in rats. Diabetes 51 (2002) 937-942
33. Noor M.A., Lo J.C., Mulligan K., et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 15 (2001) F11-F18
34. Danoff A., and Ling W.L. Protease inhibitors do not interfere with prohormone processing. Ann Intern Med 132 (2000) 330
35. Porte Jr. D., and Kahn S.E. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?. Diabetes 38 (1989) 1333-1336
36. Jones C.N., Pei D., Staris P., et al. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82 (1997) 1834-1838
37. Rossell R., Gomis R., Casamitjana R., et al. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab 56 (1983) 608-611
38. Haugaard S.B., Andersen O., Hansen B.R., et al. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance. Metabolism 54 (2005) 171-179
39. Hovorka R., Koukkou E., Southerden D., et al. Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule. Diabetologia 41 (1998) 548-554
40. Tillil H., Frank B.H., Pekar A.H., et al. Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 127 (1990) 2418-2422
41. Fritsche A., Madaus A., Stefan N., et al. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. Diabetes 51 Suppl 1 (2002) S234-S239
42. Kahn S.E., McCulloch D.K., Schwartz M.W., et al. Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab 74 (1992) 192-197
43. Ward W.K., LaCava E.C., Paquette T.L., et al. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30 (1987) 698-702
44. Reaven G.M., Chen Y.D., Hollenbeck C.B., et al. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76 (1993) 44-48
45. Roder M.E., Porte Jr. D., Schwartz R.S., et al. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83 (1998) 604-608
46. Wang P.W., Abbasi F., Carantoni M., et al. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers. J Clin Endocrinol Metab 82 (1997) 3221-3224
47. Nijpels G., Popp-Snijders C., Kostense P.J., et al. Fasting proinsulin and 2h postload glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39 (1996) 113-118
48. Haugaard S.B., Andersen O., Hales C.N., et al. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. Eur J Clin Invest 36 (2006) 436-445
49. Screening for type 2 diabetes (position statement). Diabetes Care 27 Suppl 1 (2004) S11-S14
50. Lyssenko V., Almgren P., Anevski D., et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54 (2005) 166-174
51. Bhadriraju S., Ray K.K., DeFranco A.C., et al. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUSTIMI 16 trial. Am J Cardiol 97 (2006) 1573-1577